Literature DB >> 12629500

Antidepressants and gene expression profiling: how to SNARE novel drug targets.

K P Lesch1, A Schmitt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12629500     DOI： 10.1038/sj.tpj.6500150

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN： 1470-269X            Impact factor:   3.550


× No keyword cloud information.
  8 in total

Review 1.  Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date.

Authors:  Daniel C Mathews; Ioline D Henter; Carlos A Zarate
Journal:  Drugs       Date:  2012-07-09       Impact factor: 9.546

2.  Targeting glial physiology and glutamate cycling in the treatment of depression.

Authors:  Gerald W Valentine; Gerard Sanacora
Journal:  Biochem Pharmacol       Date:  2009-04-17       Impact factor: 5.858

3.  Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus.

Authors:  Giambattista Bonanno; Roberto Giambelli; Luca Raiteri; Ettore Tiraboschi; Simona Zappettini; Laura Musazzi; Maurizio Raiteri; Giorgio Racagni; Maurizio Popoli
Journal:  J Neurosci       Date:  2005-03-30       Impact factor: 6.167

Review 4.  Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders.

Authors:  Gerard Sanacora; Carlos A Zarate; John H Krystal; Husseini K Manji
Journal:  Nat Rev Drug Discov       Date:  2008-05       Impact factor: 84.694

Review 5.  Gene-environment interaction and the genetics of depression.

Authors:  Klaus Peter Lesch
Journal:  J Psychiatry Neurosci       Date:  2004-05       Impact factor: 6.186

6.  A novel mechanism and treatment target for presynaptic abnormalities in specific striatal regions in schizophrenia.

Authors:  Vilte E Barakauskas; Clare L Beasley; Alasdair M Barr; Athena R Ypsilanti; Hong-Ying Li; Allen E Thornton; Hubert Wong; Gorazd Rosokilja; J John Mann; Branislav Mancevski; Zlatko Jakovski; Natasha Davceva; Boro Ilievski; Andrew J Dwork; Peter Falkai; William G Honer
Journal:  Neuropsychopharmacology       Date:  2010-01-13       Impact factor: 7.853

7.  Detection of lower levels of SNAP25 using multiple microarray systems and its functional significance in medulloblastoma.

Authors:  Chi-Jung Huang; Chia-Long Lee; Chih-Yi Liu; Shih-Hung Huang; Jia-Woei Hou; Yi-Hou Chen; Chih-Cheng Chien; Chih-Ming Ho; Wen-Cheng Lo; Kun-Long Hung
Journal:  Int J Mol Med       Date:  2017-03-20       Impact factor: 4.101

Review 8.  Resilience Dysregulation in Major Depressive Disorder: Focus on Glutamatergic Imbalance and Microglial Activation.

Authors:  Gislaine Z Reus; Airam B de Moura; Ritele H Silva; Wilson R Resende; Joao Quevedo
Journal:  Curr Neuropharmacol       Date:  2018-03-05       Impact factor: 7.363
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.